Register Login

DOLBY LABORATORIES, INC. (DLB)

Couling John D 🟡 adjusted position in 12.4K shares (1 derivative) of Dolby Laboratories, Inc. (DLB) at $58.47 ($1.4M) Transaction Date: May 04, 2026 | Filing ID: 209338

Full text
Register to leave comments
  • News bot May 6, 2026, 9:06 p.m.

    🔍 Couling John D (Executive)

    Company: Dolby Laboratories, Inc. (DLB)

    Report Date: 2026-05-04

    Transaction Summary:

    • Total transactions: 5
    • Derivative instruments: 1
    • Holdings reported: 0
    • Total shares acquired: 7,666
    • Total shares sold: 20,020

    Detailed Transactions and Holdings:

    • Sold 4,688 shares of Class A Common Stock at $58.465 per share (Direct)
      Date: 2026-05-04 | Code: S | equity_swap_involved: false | shares_owned_after: 118,353.00 | transaction_form_type: 4 | Footnotes: F1
    • Acquired 7,666 shares of Class A Common Stock at $45.5 per share (Direct)
      Date: 2026-05-05 | Code: M | equity_swap_involved: false | shares_owned_after: 126,019.00 | transaction_form_type: 4 | Footnotes: F1
    • Sold 6,928 shares of Class A Common Stock at $57.4708 per share (Direct)
      Date: 2026-05-05 | Code: S | equity_swap_involved: false | shares_owned_after: 119,091.00 | transaction_form_type: 4 | Footnotes: F2, F1
    • Sold 738 shares of Class A Common Stock at $58.3354 per share (Direct)
      Date: 2026-05-05 | Code: S | equity_swap_involved: false | shares_owned_after: 118,353.00 | transaction_form_type: 4 | Footnotes: F3, F1
    • Sold 7,666 shares of Employee Stock Option (Right to Buy) at $45.5 per share (Derivative)
      Date: 2026-05-05 | Code: M | Expires: 2026-12-15 | equity_swap_involved: false | shares_owned_after: 38,334.00 | transaction_form_type: 4 | Footnotes: F4

    Footnotes:

    • F1: Shares held following the reported transactions include 55,114 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest.
    • F2: The shares were sold in multiple transactions at prices ranging from $57.16 to $58.05 , inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. The shares were sold pursuant to a 10b5-1 trading plan adopted on February 3, 2026.
    • F3: The shares were sold in multiple transactions at prices ranging from $58.195 to $58.36, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. The shares were sold pursuant to a 10b5-1 trading plan adopted on February 3, 2026.
    • F4: This option was granted for a total of 46,000 shares of Class A Common Stock. The option exercised in this transation was fully vested and exercisable as of the transaction date.

Search

News categories